PANTHERx
- Website
- pantherxrare.com
- Total Funding
- $1.4B
- Last Round
- $1.4B Private EquityMay 2022
- Rounds
- 1
About
PANTHERx is a specialty pharmacy focused on the rare & orphan patient population.
Summary
PANTHERx is a Healthcare company based in United States. It has raised $1.4B in total across 1 round, most recently a $1.4B Private Equity round in May 2022. Investors include The Vistria Group, General Atlantic and Nautic Partners.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2022
Investors
Similar Companies
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.